Stan V. Smith - 01 Nov 2024 Form 4 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role
Director
Signature
/s/ Stan V. Smith
Issuer symbol
MAIA
Transactions as of
01 Nov 2024
Net transactions value
+$476,900
Form type
4
Filing time
04 Nov 2024, 16:34:28 UTC
Previous filing
02 Oct 2024
Next filing
13 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MAIA Common Stock Purchase $251,000 +100,000 +12% $2.51 957,568 01 Nov 2024 See Footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MAIA Warrants Purchase $225,900 +100,000 $2.26 100,000 01 Nov 2024 Common Stock 100,000 $2.26 See Footnote F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on November 1, 2024.
F2 These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
F3 These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on November 1, 2024. The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date.
F4 These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.